WiTii Pharmaceuticals

WiTii is a Colorado-founded, preclinical-stage technology spin-off of the University of Wyoming (UOW), advancing a first-in-class small-molecule therapy for diabetic foot ulcers. With a global exclusive license from UOW and two issued U.S. patents, WiTii is poised to address a major unmet need in wound care.